Jiangsu Simcere Pharmaceutical Co., Ltd – Trademark Portfolio

Entity Type: 03

Jiangsu Simcere Pharmaceutical Co., Ltd holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIMCERE.

No.699-18, Xuanwu Avenue,

Xuanwu District, Nanjing City, Jiangsu P

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SIMCERE
SIMCERE
Registered 2019
SIMCERE
SIMCERE
Abandoned 2007
ENDOSTAR
ENDOSTAR
Abandoned 2007
SCR
SCR
Abandoned 2007

Trademark Classifications

Jiangsu Simcere Pharmaceutical Co., Ltd's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Jiangsu Simcere Pharmaceutical Co., Ltd have?

Jiangsu Simcere Pharmaceutical Co., Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 1 cancelled.

What trademark classes does Jiangsu Simcere Pharmaceutical Co., Ltd file in?

Jiangsu Simcere Pharmaceutical Co., Ltd files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jiangsu Simcere Pharmaceutical Co., Ltd's most well-known trademarks?

Jiangsu Simcere Pharmaceutical Co., Ltd's registered trademark portfolio includes well-known marks such as SIMCERE. These are among 1 currently registered trademark in the portfolio.

What is Jiangsu Simcere Pharmaceutical Co., Ltd's trademark registration success rate?

Jiangsu Simcere Pharmaceutical Co., Ltd has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.